Annual Revenue
N/A
September 30, 2024
Summary
- OTLK annual revenue is not available.
Performance
OTLK Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 1, 2024
Summary
- OTLK quarterly revenue is not available.
Performance
OTLK Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 1, 2024
Summary
- OTLK TTM revenue is not available.
Performance
OTLK TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
OTLK Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
OTLK Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Outlook Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | $8.15 M(+163.8%) | $5.85 M(+902.7%) | $8.15 M(+165.8%) |
| Jun 2019 | - | $583.80 K(-8.9%) | $3.06 M(-5.8%) |
| Mar 2019 | - | $641.10 K(-39.9%) | $3.25 M(-3.9%) |
| Dec 2018 | - | $1.07 M(+38.3%) | $3.38 M(+9.6%) |
| Sep 2018 | $3.09 M(-19.0%) | $771.90 K(0.0%) | $3.09 M(-40.8%) |
| Jun 2018 | - | $771.90 K(0.0%) | $5.22 M(+9.9%) |
| Mar 2018 | - | $771.90 K(0.0%) | $4.75 M(+11.0%) |
| Dec 2017 | - | $771.90 K(-73.4%) | $4.28 M(+12.3%) |
| Sep 2017 | $3.81 M | $2.90 M(+857.5%) | $3.81 M(+171.4%) |
| Jun 2017 | - | $303.10 K(0.0%) | $1.40 M(-12.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $303.10 K(0.0%) | $1.60 M(-30.2%) |
| Dec 2016 | - | $303.10 K(-38.8%) | $2.29 M(-23.2%) |
| Sep 2016 | $2.98 M(-42.9%) | $494.90 K(0.0%) | $2.98 M(0.0%) |
| Jun 2016 | - | $494.90 K(-50.3%) | $2.98 M(-21.2%) |
| Mar 2016 | - | $994.90 K(0.0%) | $3.78 M(+15.2%) |
| Dec 2015 | - | $994.90 K(+101.0%) | $3.28 M(-37.2%) |
| Sep 2015 | $5.22 M(-42.3%) | $494.90 K(-61.8%) | $5.22 M(+10.5%) |
| Jun 2015 | - | $1.29 M(+161.6%) | $4.72 M(+37.8%) |
| Mar 2015 | - | $494.90 K(-83.1%) | $3.43 M(+16.9%) |
| Dec 2014 | - | $2.93 M | $2.93 M |
| Sep 2014 | $9.05 M | - | - |
FAQ
- What is the all time high annual revenue for Outlook Therapeutics?
- What is the all time high quarterly revenue for Outlook Therapeutics?
- What is the all time high TTM revenue for Outlook Therapeutics?
What is the all time high annual revenue for Outlook Therapeutics?
Outlook Therapeutics all-time high annual revenue is $9.05 M
What is the all time high quarterly revenue for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly revenue is $5.85 M
What is the all time high TTM revenue for Outlook Therapeutics?
Outlook Therapeutics all-time high TTM revenue is $8.15 M